{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:48:59Z","timestamp":1771631339575,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of our study was to evaluate the risk for comorbid cardio- and cerebrovascular diseases in the working-aged migraine population of Finland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1505 cases who reported diagnosed migraine and 3010 controls from a cohort of 11,596 cases in the Finnish Health and Social Support Study were included. The study material was linked with two registers. ICD diagnoses I63 for ischemic stroke (IS), I21\u2009\u2212\u2009I22 for acute myocardial infarction (AMI), and G43 for transient ischemic attack (TIA) among study participants were drawn from the national Finnish Care Register for Health Care at the follow-up in 2012. Reimbursed triptan prescriptions were drawn from the national Social Security Institution (SII) data. The self-reported vascular risk factors were hypertension, high cholesterol values, any diabetes, myocardial infarction, stroke, and TIA. Odds Ratios (OR) with 95% confidence (95% CI) intervals were assessed for diagnosed stroke, myocardial infarction, and TIA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Migraineurs were mostly female (82%) and\u2009\u2265\u200954\u2009years old (62%). Triptans were reimbursed among 34.7% of migraineurs. A self-reported hypertension (21%), high serum cholesterol (38%), and any diabetes (7%) were more common among migraineurs vs controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). There was no risk for AMI. The risk for TIA (OR 3.20, 95% CI 1.45\u20137.05) and IS (2.57, 95% CI 1.28\u20135.17) among migraineurs vs controls remained high after adjustment for self-reported hypertension, obesity, and smoking. The risk was higher among women in two groups \u226554\u2009years (3.25, 95% CI 1.35\u20137.84 and 5.0, 95% CI 1.94\u201312.89, respectively). The average age for IS in migraine was 57.5\u2009years and for TIA 58.2\u2009years among women, and 52.8\u2009years and 50.3\u2009years among men, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cardiovascular risk should be screened in the aging migraine population, and hormonal and other migraine-related risk factors should be considered, especially among women. Efficacious attack treatment with triptans should be offered to migraine patients who do not show contraindications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11006-1","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:07:12Z","timestamp":1623071232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stroke and cardiovascular risk factors among working-aged Finnish migraineurs"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-0483","authenticated-orcid":false,"given":"Marja-Liisa","family":"Sumelahti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merika S.","family":"Sumanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari J.","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri","family":"Sillanm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Sumanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"11006_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1212\/WNL.53.3.537","volume":"53","author":"LJ Launer","year":"1999","unstructured":"Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537\u201342.","journal-title":"Neurology"},{"key":"11006_CR2","doi-asserted-by":"crossref","unstructured":"Eriksen MK, Thomsen LL, Russell MB. Prognosis of migraine with aura. Cephalalgia, 2004-01, Vol.24 (1), p.18-2.","DOI":"10.1111\/j.1468-2982.2004.00622.x"},{"key":"11006_CR3","doi-asserted-by":"publisher","unstructured":"Mahmoud AN, Mentias A, Elgendy AY, et al. Migraine and the risk of cardiovascular andcerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open. 2018;8(3):e020498. https:\/\/doi.org\/10.1136\/bmjopen-2017-020498.","DOI":"10.1136\/bmjopen-2017-020498"},{"key":"11006_CR4","doi-asserted-by":"crossref","unstructured":"Schurks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.","DOI":"10.1136\/bmj.b3914"},{"key":"11006_CR5","doi-asserted-by":"crossref","unstructured":"Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123:612\u201324.","DOI":"10.1016\/j.amjmed.2009.12.021"},{"key":"11006_CR6","doi-asserted-by":"crossref","unstructured":"Kurth T, Diener HC. Migraine and Stroke. Perspectives for Stoke Physicians. Stroke 2012;43:3421\u20133426.","DOI":"10.1161\/STROKEAHA.112.656603"},{"key":"11006_CR7","doi-asserted-by":"crossref","unstructured":"Malik R, Freilinger T, Winsvold BS, et al. METASTROKE Collaboration of the International Stroke Genetics Consortium. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology. 2015;84(21):2132\u201345.","DOI":"10.1212\/WNL.0000000000001606"},{"key":"11006_CR8","unstructured":"Winsvold BS, Nelson CP, Malik R, et al. CARDIoGRAM Consortium and the International Headache Genetics Consortium. Genetic analysis for a shared biological basis between migraine and coronary artery disease. Neurol Genet. 2015;1(1):e10."},{"key":"11006_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1023\/A:1020016922473","volume":"17","author":"K Korkeila","year":"2001","unstructured":"Korkeila K, Suominen S, Ahvenainen J, et al. Non-response and related factors in a nation-wide health survey. Eur J Epidemiol. 2001;17:991\u20139.","journal-title":"Eur J Epidemiol"},{"key":"11006_CR10","doi-asserted-by":"publisher","first-page":"e000657","DOI":"10.1136\/bmjopen-2011-000657","volume":"2","author":"S Suominen","year":"2012","unstructured":"Suominen S, Koskenvuo K, Sillanm\u00e4ki L, et al. Non-response in a nationwide follow-up postal survey in Finland: a register-based mortality analysis of respondents and non-respondents of the Health and Social Support (HeSSup) Study. BMJ Open. 2012;2:e000657.","journal-title":"BMJ Open"},{"key":"11006_CR11","unstructured":"Health and long-term care in the European Union\" (PDF). European Commission. 2000. Retrieved August 3, 2015."},{"key":"11006_CR12","unstructured":"Current Care Guideline: Migraine. Duodecim 2015;131(19):1823\u20131825."},{"key":"11006_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","volume":"9","author":"P Jousilahti","year":"1999","unstructured":"Jousilahti P, Vartiainen E, Tuomilehto J, et al. Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease. A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland. Circulation. 1999;9:1165\u201372.","journal-title":"Circulation"},{"issue":"14","key":"11006_CR14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1177\/0333102418767999","volume":"38","author":"A Terrin","year":"2018","unstructured":"Terrin A, Toldo G, Ermani M, et al. When migraine mimics stroke: A systematic review. Cephalalgia. 2018;38(14):2068\u201378.","journal-title":"Cephalalgia."},{"key":"11006_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1468-1331.2011.03364.x","volume":"18","author":"K Laurell","year":"2011","unstructured":"Laurell K, Artto V, Bendtsen L, Hagen K, Kallela M, Meyer EL, et al. Migrainous infarction: a Nordic multicenter study. Eur J Neurol. 2011;18:1220\u20136.","journal-title":"Eur J Neurol"},{"issue":"3","key":"11006_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/STROKEAHA.115.010613","volume":"47","author":"AE Arch","year":"2016","unstructured":"Arch AE, Weisman DC, Coca S, et al. Missed Ischemic Stroke Diagnosis in the Emergency Department by Emergency Medicine and Neurology Services. Stroke. 2016;47(3):668\u201373.","journal-title":"Stroke"},{"issue":"6","key":"11006_CR17","doi-asserted-by":"publisher","first-page":"e00950","DOI":"10.1002\/brb3.950","volume":"8","author":"WZ Yeh","year":"2018","unstructured":"Yeh WZ, Blizzard L, Taylor BV. What is the actual prevalence of migraine? Brain Behav. 2018;8(6):e00950.","journal-title":"Brain Behav"},{"issue":"10046","key":"11006_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761\u201375.","journal-title":"Lancet"},{"key":"11006_CR19","doi-asserted-by":"publisher","first-page":"c3966","DOI":"10.1136\/bmj.c3966","volume":"341","author":"LS Gudmundsson","year":"2010","unstructured":"Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all-cause mortality in men and women: prospective cohort study. BMJ. 2010;341:c3966.","journal-title":"BMJ"},{"issue":"9","key":"11006_CR20","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/ene.13060","volume":"23","author":"J Norton","year":"2016","unstructured":"Norton J, Portet F, Gabelle A, et al. Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up. Eur J Neurol. 2016;23(9):1463\u201370.","journal-title":"Eur J Neurol"},{"key":"11006_CR21","first-page":"3032","volume":"44","author":"S Sacco","year":"2013","unstructured":"Sacco S, Ornello R, Ripa P, et al. Migraine and Hemorrhagic Stroke. A Meta-analysis. Stroke. 2013;44:3032\u20138.","journal-title":"A Meta-analysis. Stroke"},{"key":"11006_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-015-0510-z","volume":"16","author":"R Ornello","year":"2015","unstructured":"Ornello R, Ripa P, Pistoia F, et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015;16:27.","journal-title":"J Headache Pain"},{"key":"11006_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","volume":"18","author":"S Sacco","year":"2017","unstructured":"Sacco S, Merki-Feld G, Lehrman K, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017;18:108.","journal-title":"J Headache Pain"},{"key":"11006_CR24","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth T, Winter AC, Eliassen AH, et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016;353:i2610.","journal-title":"BMJ"},{"key":"11006_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/eurpub\/ckt141","volume":"24","author":"A Entonen","year":"2014","unstructured":"Entonen A, Suominen S, Korkeila K, et al. Migraine predicts hypertension-a cohort study of the Finnish working-age population. Eur J Public Health. 2014;24:244\u20138.","journal-title":"Eur J Public Health"},{"issue":"12","key":"11006_CR26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1177\/0333102418756865","volume":"38","author":"PM Rist","year":"2018","unstructured":"Rist PM, Winter AC, Buring JE, et al. Migraine and the risk of incident hypertension among women. Cephalalgia. 2018;38(12):1817\u201324.","journal-title":"Cephalalgia"},{"key":"11006_CR27","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1097\/HJH.0000000000000379","volume":"32","author":"C Thomopoulos","year":"2014","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effect of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2296\u2013304.","journal-title":"J Hypertens"},{"issue":"3","key":"11006_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","volume":"61","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Dodick D, Sadovsky R, et al. Self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61(3):375\u201382.","journal-title":"Neurology"},{"key":"11006_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10194-016-0605-1","volume":"17","author":"BS Kim","year":"2016","unstructured":"Kim BS, Moon HS, Sohn JH, et al. Short-term diagnostic stability of probable headache disorders based on the International Classification of Headache Disorders, 3rd edition beta version, in first-visit patients: a multicenter follow-up study. J Headache Pain. 2016;17:13.","journal-title":"J Headache Pain"},{"issue":"7","key":"11006_CR30","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/01.wnl.0000240128.76399.fa","volume":"67","author":"EA Wammes-van der Heijden","year":"2005","unstructured":"Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. 2005;67(7):1128\u201334.","journal-title":"Neurology"},{"issue":"6","key":"11006_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00228-016-2028-y","volume":"72","author":"P Frisk","year":"2016","unstructured":"Frisk P, Sporrong SK, Ljunggren G, et al. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden. Eur J Clin Pharmacol. 2016;72(6):747\u201354.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"11006_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/head.12553","volume":"55","author":"D Serrano","year":"2015","unstructured":"Serrano D, Buse DC, Manack Adams A, et al. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2015;55(4):502\u201318.","journal-title":"Headache"},{"key":"11006_CR33","doi-asserted-by":"publisher","first-page":"k96","DOI":"10.1136\/bmj.k96","volume":"360","author":"K Adelborg","year":"2018","unstructured":"Adelborg K, Sz\u00e9pligeti SK, Holland-Bill L, et al. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018;360:k96.","journal-title":"BMJ"},{"issue":"8","key":"11006_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1177\/0333102417736901","volume":"38","author":"ER Lebedeva","year":"2018","unstructured":"Lebedeva ER, Gurary NM, Gilev DV, et al. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. Cephalalgia. 2018;38(8):1463\u201370.","journal-title":"Cephalalgia"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11006-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:08:27Z","timestamp":1623071307000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11006"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11006-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"25 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Turku University Central Hospital Ethics Committee has approved the study and the written consent form. Respondents have given their written permission for the collation of information with the official registers. Permission was granted by the Finnish Social Insurance Institution (Kela 145\/522\/2018) and the National Institute for Health and Welfare (THL\/2296\/5.05.00\/2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1088"}}